Anesthetic considerations in mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes syndrome: A case series

Canadian Journal of Anesthesia

Volumn 58, Issue 8, 2011, Pages 751-763

  Gurrieri, Carmelina ^a   Kivela, Jonathon E ^a   Bojanić, Katarina ^a   Gavrilova, Ralitza H ^a   Flick, Randall P ^a   Sprung, Juraj ^a   Weingarten, Toby N ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISATRACURIUM; DESFLURANE; ETOMIDATE; FENTANYL; HALOTHANE; HYDROMORPHONE; ISOFLURANE; KETAMINE; LACTIC ACID; MIDAZOLAM; NEOSTIGMINE; NITROUS OXIDE; PANCURONIUM; PROPOFOL; RINGER LACTATE SOLUTION; SEVOFLURANE; SUXAMETHONIUM; THIOPENTAL; VECURONIUM;

ABDOMINAL SURGERY; ADOLESCENT; ADULT; AGED; ANESTHESIA INDUCTION; AORTA VALVE REGURGITATION; ARTICLE; BRAIN DISEASE; CARDIOMYOPATHY; CASE STUDY; CHILD; CLINICAL ARTICLE; COMORBIDITY; COMPLETE HEART BLOCK; DISEASE SEVERITY; DRUG TOLERABILITY; FEMALE; GENERAL ANESTHESIA; HEART SURGERY; HUMAN; HUMAN TISSUE; HYPERKALEMIA; HYPONATREMIA; KIDNEY FAILURE; LACTATE BLOOD LEVEL; LACTIC ACIDEMIA; MALE; MEDICAL RECORD REVIEW; MELAS SYNDROME; MUSCLE WEAKNESS; MYOPATHY; PRIORITY JOURNAL; SCHOOL CHILD; SEIZURE; SEPSIS; STROKE; WOLFF PARKINSON WHITE SYNDROME;

ADULT; AGED; ANESTHESIA, GENERAL; ANESTHETICS, GENERAL; CHILD; FEMALE; HUMANS; HYPERKALEMIA; HYPONATREMIA; MALE; MELAS SYNDROME; MIDDLE AGED; NEUROMUSCULAR DEPOLARIZING AGENTS; POSTOPERATIVE COMPLICATIONS; SEVERITY OF ILLNESS INDEX; SUCCINYLCHOLINE; YOUNG ADULT;

EID: 79960440494     PISSN: 0832610X     EISSN: 14968975     Source Type: Journal    
DOI: 10.1007/s12630-011-9528-0     Document Type: Article

References (50)

1. SG Pavlakis PC Phillips S DiMauro DC De Vivo LP Rowland 1984 Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome Ann Neurol 16 481 488 6093682 10.1002/ana.410160409 1:STN:280:DyaL2M%2FksFequg%3D%3D (Pubitemid 14021826)
2. Y Goto I Nonaka S Horai 1990 A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies Nature 348 651 653 2102678 10.1038/348651a0 1:CAS:528:DyaK3MXls1Kqsw%3D%3D (Pubitemid 120015131)
3. BH Cohen DR Gold 2001 Mitochondrial cytopathy in adults: what we know so far Cleve Clin J Med 68 625 642 11453081 10.3949/ccjm.68.7.625 1:STN:280:DC%2BD3Mvgt1Ghtg%3D%3D (Pubitemid 32634614)
4. Y Goto 1995 Clinical features of MELAS and mitochondrial DNA mutations Muscle Nerve 3 S107 S112 7603510 10.1002/mus.880181422 1:STN:280: DyaK2MzislWgsw%3D%3D
5. DM Sproule P Kaufmann 2008 Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome Ann N Y Acad Sci 1142 133 158 18990125 10.1196/annals.1444.011 1:CAS:528:DC%2BD1cXhsV2hsb7P
6. P Kaufmann K Engelstad Y Wei, et al. 2006 Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial Neurology 66 324 330 16476929 10.1212/01.wnl.0000196641.05913.27 1:CAS:528:DC%2BD28Xnt1CktQ%3D%3D (Pubitemid 43739931)
7. MT Aouad FJ Gerges AS Baraka 2005 Resistance to cisatracurium in a patient with MELAS syndrome Pediatr Anesth 15 1124 1127 (Pubitemid 43965395)
8. J Finsterer U Stratil R Bittner P Sporn 1998 Increased sensitivity to rocuronium and atracurium in mitochondrial myopathy Can J Anaesth 45 781 784 9793668 10.1007/BF03012149 1:STN:280:DyaK1M%2FhtVSrsQ%3D%3D (Pubitemid 28550513)
9. NA Wisely PR Cook 2001 General anaesthesia in a man with mitochondrial myopathy undergoing eye surgery Eur J Anaesthesiol 18 333 335 11350477 1:STN:280:DC%2BD3M3lt1CmtQ%3D%3D (Pubitemid 32417800)
10. M Naguib AA el Dawlatly M Ashour M al-Bunyan 1996 Sensitivity to mivacurium in a patient with mitochondrial myopathy Anesthesiology 84 1506 1509 8669694 10.1097/00000542-199606000-00029 1:STN:280:DyaK283lvVyjtw%3D%3D (Pubitemid 26192061)
11. A Maslow A Lisbon 1993 Anesthetic considerations in patients with mitochondrial dysfunction Anesth Analg 76 884 886 8466034 10.1213/00000539- 199304000-00035 1:STN:280:DyaK3s3itV2isA%3D%3D (Pubitemid 23107615)
12. PF Chinnery DM Turnbull 2001 Epidemiology and treatment of mitochondrial disorders Am J Med Genet 106 94 101 11579428 10.1002/ajmg.1426 1:STN:280:DC%2BD3MrjtVyksg%3D%3D (Pubitemid 32601621)
13. MN D'Ambra D Dedrick JJ Savarese 1979 Kearns-Sayer syndrome and pancuronium-succinylcholine-induced neuromuscular blockade Anesthesiology 51 343 345 225968 10.1097/00000542-197910000-00014 (Pubitemid 10246040)
14. S Parikh R Saneto MJ Falk, et al. 2009 A modern approach to the treatment of mitochondrial disease Curr Treat Options Neurol 11 414 430 19891905 10.1007/s11940-009-0046-0
15. N Sasano Y Fujita M So K Sobue H Sasano H Katsuya 2007 Anesthetic management of a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) during laparotomy J Anesth 21 72 75 17285419 10.1007/s00540-006-0449-y (Pubitemid 46487044)
16. DiMauro S, Bonilla E. Mitochondrial encephalomyopathies. In: Engel AG, Franzini-Armstrong C (Eds). Myology. 3rd ed. NY: Mc-Graw-Hill, Medical Publishing Division; 2003: 1623-62.
17. A Fayssoil 2009 Heart diseases in mitochondrial encephalomyopathy, lactic acidosis, and stroke syndrome Congest Heart Fail 15 284 287 19925507 10.1111/j.1751-7133.2009.00108.x 1:CAS:528:DC%2BC3cXltVWltw%3D%3D
18. N Sasano T Tamura T Azami H Sasano 2009 Severe hyponatremia occurring after surgical stress in a patient with mitochondrial disease J Anesth 23 587 590 19921372 10.1007/s00540-009-0808-6
19. H Kubota Y Tanabe J Takanashi Y Kohno 2005 Episodic hyponatremia in mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes (MELAS) J Child Neurol 20 116 120 15794176 10.1177/08830738050200020601 (Pubitemid 40484850)
20. HJ Southgate MD Penney 2000 Severe recurrent renal salt wasting in a boy with a mitochondrial oxidative phosphorylation defect Ann Clin Biochem 37 Pt 6 805 808 11085630 10.1258/0004563001900002
21. RG Boles T Roe D Senadheera V Mahnovski LJ Wong 1998 Mitochondrial DNA deletion with Kearns Sayre syndrome in a child with Addison disease Eur J Pediatr 157 643 647 9727847 10.1007/s004310050902 1:CAS:528:DyaK1cXlvFagsbw%3D (Pubitemid 28381180)
22. J Shimizu A Inatsu S Oshima, et al. 2008 Hyperkalemia in familial mitochondrial cytopathy Clin Nephrol 70 348 353 18826862 1:CAS:528: DC%2BD1cXhtl2gtrvK
23. T Kadowaki H Kadowaki Y Mori, et al. 1994 A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA N Engl J Med 330 962 968 8121460 10.1056/NEJM199404073301403 1:CAS:528:DyaK2cXmvFyntrw%3D (Pubitemid 24103594)
24. S Lessell T Kuwabara RG Feldman 1969 Myopathy and succinylcholine sensitivity Am J Ophthalmol 68 789 796 5352598 1:STN:280:DyaE3c%2FjslWkug%3D%3D
25. MJ Brodie MA Dichter 1996 Antiepileptic drugs N Engl J Med 334 168 175 8531974 10.1056/NEJM199601183340308 1:CAS:528:DyaK28Xos1Gltg%3D%3D (Pubitemid 26017957)
26. HI Pirttiaho EA Sotaniemi RO Pelkonen U Pitkanen 1982 Hepatic blood flow and drug metabolism in patients on enzyme-inducing anticonvulsants Eur J Clin Pharmacol 22 441 445 7117357 10.1007/BF00542550 1:CAS:528:DyaL38Xlt1Sisro%3D (Pubitemid 12045986)
27. SG Soriano JA Martyn 2004 Antiepileptic-induced resistance to neuromuscular blockers: mechanisms and clinical significance Clin Pharmacokinet 43 71 81 14748617 10.2165/00003088-200443020-00001 1:CAS:528: DC%2BD2cXisFGkurg%3D (Pubitemid 38283131)
28. JM Kremer J Wilting LH Janssen 1988 Drug binding to human alpha-1-acid glycoprotein in health and disease Pharmacol Rev 40 1 47 3064105 1:CAS:528:DyaL1cXlsVWqs74%3D
29. M Wood 1991 Plasma binding and limitation of drug access to site of action Anesthesiology 75 721 723 1952195 10.1097/00000542-199111000-00001 1:STN:280:DyaK38%2FmtVSlsA%3D%3D
30. R Tempelhoff PA Modica WS Jellish EL Spitznagel 1990 Resistance to atracurium-induced neuromuscular blockade in patients with intractable seizure disorders treated with anticonvulsants Anesth Analg 71 665 669 2240640 10.1213/00000539-199012000-00015 1:STN:280:DyaK3M%2Flt1CksQ%3D%3D
31. PM Wright G McCarthy J Szenohradszky ML Sharma JE Caldwell 2004 Influence of chronic phenytoin administration on the pharmacokinetics and pharmacodynamics of vecuronium Anesthesiology 100 626 633 15108978 10.1097/00000542-200403000-00024 1:CAS:528:DC%2BD2cXis1Kjtbk%3D (Pubitemid 38268882)
32. JA Martyn DA White GA Gronert RS Jaffe JM Ward 1992 Up-and-down regulation of skeletal muscle acetylcholine receptors. Effects on neuromuscular blockers Anesthesiology 76 822 843 1575351 10.1097/00000542-199205000-00022 1:CAS:528:DyaK38Xkt1SmtLo%3D
33. HS Gray RM Slater BJ Pollard 1989 The effect of acutely administered phenytoin on vecuronium-induced neuromuscular blockade Anaesthesia 44 379 381 2568098 10.1111/j.1365-2044.1989.tb11331.x 1:CAS:528:DyaL1MXktFOitLc%3D (Pubitemid 19125317)
34. P Audu LI Kim MY Mehta J Kim 2006 Newer anti-epileptic drugs do not cause resistance to non-depolarizing neuromuscular blockade Anesthesiology 105 A115 10.1097/00000542-200611000-00009 (abstract) (Pubitemid 44655499)
35. H Hara Y Wakayama Y Kouno H Yamada M Tanaka T Ozawa 1994 Acute peripheral neuropathy, rhabdomyolysis, and severe lactic acidosis associated with 3243 A to G mitochondrial DNA mutation J Neurol Neurosurg Psychiatry 57 1545 1546 7798993 10.1136/jnnp.57.12.1545-a 1:STN:280:DyaK2M%2Fps12itQ%3D%3D
36. JH Kwon JS Kim 2003 Rhabdomyolysis in a patient with MELAS syndrome Eur Neurol 50 123 124 12944725 10.1159/000072517 (Pubitemid 37116981)
37. PA Gabow WD Kaehny SP Kelleher 1982 The spectrum of rhabdomyolysis Medicine (Baltimore) 61 141 152 1:STN:280:DyaL387psVOgsw%3D%3D (Pubitemid 12073570)
38. S Blum T Robertson S Klingberg RD Henderson P McCombe 2011 Atypical clinical presentations of the A3243G mutation, usually associated with MELAS Internal Medicine Journal 41 199 202 10.1111/j.1445-5994.2010.02379.x
39. M Lofberg H Jankala A Paetau M Harkonen H Somer 1998 Metabolic causes of recurrent rhabdomyolysis Acta Neurol Scand 98 268 275 9808277 10.1111/j.1600-0404.1998.tb07307.x 1:STN:280:DyaK1M%2FitlClsQ%3D%3D (Pubitemid 28462086)
40. BS Connolly AS Feigenbaum BH Robinson AI Dipchand DK Simon MA Tarnopolsky 2010 MELAS syndrome, cardiomyopathy, rhabdomyolysis, and autism associated with the A3260G mitochondrial DNA mutation Biochem Biophys Res Commun 402 443 447 20965148 10.1016/j.bbrc.2010.10.060 1:CAS:528:DC%2BC3cXhsValtr3L
41. RM Fricker T Raffelsberger S Rauch-Shorny, et al. 2002 Positive malignant hyperthermia susceptibility in vitro test in a patient with mitochondrial myopathy and myoadenylate deaminase deficiency Anesthesiology 97 1635 1637 12459698 10.1097/00000542-200212000-00044 (Pubitemid 35417469)
42. J Ohtani T Miike T Ishitsu 1985 A case of malignant hyperthermia with mitochondrial dysfunction Brain Dev 7 249
43. RP Flick SJ Gleich MM Herr DJ Wedel 2007 The risk of malignant hyperthermia in children undergoing muscle biopsy for suspected neuromuscular disorder Pediatr Anesth 17 22 27 10.1111/j.1460-9592.2006.02105.x (Pubitemid 44924373)
44. M Maurtua A Torres V Ibarra G DeBoer J Dolak 2008 Anesthetic management of an obstetric patient with MELAS syndrome: case report and literature review Int J Obstet Anesth 17 370 373 18691868 10.1016/j.ijoa.2007.11.011 1:STN:280:DC%2BD1cngtFSkuw%3D%3D
45. DM Sproule P Kaufmann K Engelstad TJ Starc AJ Hordof DC De Vivo 2007 Wolff-Parkinson-White syndrome in patients with MELAS Arch Neurol 64 1625 1627 17998445 10.1001/archneur.64.11.1625 (Pubitemid 350106764)
46. M Hirano E Ricci MR Koenigsberger, et al. 1992 Melas: an original case and clinical criteria for diagnosis Neuromuscul Disord 2 125 135 1422200 10.1016/0960-8966(92)90045-8 1:STN:280:DyaK3s%2FksVCltw%3D%3D
47. Y Okajima Y Tanabe M Takayanagi H Aotsuka 1998 A follow up study of myocardial involvement in patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) Heart 80 292 295 9875091 1:STN:280:DyaK1M%2Fpt1amsg%3D%3D (Pubitemid 28440350)
48. E Salsano AR Giovagnoli L Morandi, et al. 2011 Mitochondrial dementia: a sporadic case of progressive cognitive and behavioral decline with hearing loss due to the rare m.3291T>C MELAS mutation J Neurol Sci 300 165 168 20943236 10.1016/j.jns.2010.09.022 1:CAS:528:DC%2BC3cXhs1WgtLfN
49. W Sato M Tanaka S Sugiyama, et al. 1994 Cardiomyopathy and angiopathy in patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes Am Heart J 128 733 741 7942444 10.1016/0002-8703(94)90272-0 1:STN:280:DyaK2M%2FivV2gug%3D%3D (Pubitemid 24314662)
50. M Yoneda M Tanaka M Nishikimi, et al. 1989 Pleiotropic molecular defects in energy-transducing complexes in mitochondrial encephalomyopathy (MELAS) J Neurol Sci 92 143 158 2809615 10.1016/0022-510X(89)90132-9 1:CAS:528: DyaL1MXmtFaqs74%3D (Pubitemid 19241800)